Effect of dry tomato peel supplementation on glucose tolerance, insulin resistance, and hepatic markers in mice fed high-saturated-fat/high-cholesterol diets

Journal of Nutritional Biochemistry

Volumn 40, Issue , 2017, Pages 164-171

  Zidani, Sofiane ^a   Benakmoum, Amar ^a   Ammouche, Ali ^b   Benali, Yasmine ^c   Bouhadef, Anissa ^c   Abbeddou, Souheila ^d  

^a UNIVERSITY OF BOUMERDES   (Algeria)

^b Algeria 3INATAA University of Constatntine   (Algeria)

^c Institut Pasteur d'Algerie   (Algeria)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dry tomato peel; Glucose tolerance; High saturated fat high cholesterol diet; Insulin resistance; Lycopene; Mice; Type 2 diabetes

Indexed keywords

GLUCOSE; LYCOPENE; SATURATED FATTY ACID; SUNFLOWER OIL; BIOLOGICAL MARKER; CAROTENOID;

ADIPOSE TISSUE; ADULT; ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL DIET; DIET SUPPLEMENTATION; DIET THERAPY; DRY TOMATO PEEL; EXPERIMENTAL FATTY LIVER; EXPERIMENTAL HEPATITIS; FAT PAD; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; LIPID BLOOD LEVEL; LIPID DIET; LIPID PEROXIDATION; LIVER WEIGHT; MALE; METABOLIC SYNDROME X; MOUSE; NONHUMAN; NUTRITIONAL VALUE; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; OXIDATIVE STRESS; TOMATO; WEIGHT GAIN; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CHOLESTEROL INTAKE; DIETARY SUPPLEMENT; GLUCOSE INTOLERANCE; INFLAMMATION; LIVER; METABOLISM; NONALCOHOLIC FATTY LIVER; PATHOLOGY;

ANIMALS; BIOMARKERS; CAROTENOIDS; CHOLESTEROL, DIETARY; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; GLUCOSE INTOLERANCE; INFLAMMATION; INSULIN RESISTANCE; LIVER; LYCOPERSICON ESCULENTUM; MALE; MICE, INBRED BALB C; NON-ALCOHOLIC FATTY LIVER DISEASE; WEIGHT GAIN;

EID: 84998953617     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2016.11.001     Document Type: Article

References (54)

1. [1] Wang, X., Ouyang, Y., Liu, J., Zhu, M., Zhao, G., Bao, W., et al. Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose–response meta-analysis of prospective cohort studies. Br Med J, 349, 2014.
2. [2] Joint WHO/FAO expert consultation: diet, nutrition and the prevention of chronic diseases, vol. 916, 2003, WHO, Geneva, Switzerland, 149.
3. [3] Seifried, H.E., Anderson, D.E., Fisher, E.I., Milner, J.A., A review of the interaction among dietary antioxidants and reactive oxygen species. J Nutr Biochem 18 (2007), 567–579.
4. [4] Danaei, G., Finucane, M.M., Lu, Y., Singh, G.M., Cowan, M.J., Paciorek, C.J., et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378 (2011), 31–40.
5. [5] Ten facts about diabetes. http://www.who.int/features/factfiles/diabetes/01_en.html.
6. [6] Avignon, A., Hokayem, M., Bisbal, C., Lambert, K., Dietary antioxidants: do they have a role to play in the ongoing fight against abnormal glucose metabolism?. Nutrition 28 (2012), 715–721.
7. [7] Bloch-Damti, A., Bashan, N., Proposed mechanisms for the induction of insulin resistance by oxidative stress. Antioxid Redox Signal 7 (2005), 1553–1567.
8. [8] Campbell, J.K., Canene-Adams, K., Lindshield, B.L., Boileau, T.W., Clinton, S.K., Erdman, J.W. Jr., Tomato phytochemicals and prostate cancer risk. J Nutr 134 (2004), 3486S–3492S.
9. [9] Agarwal, S., Rao, A.V., Tomato lycopene and low density lipoprotein oxidation: a human dietary intervention study. Lipids 33 (1998), 981–984.
10. [10] Alshatwi, A.A., Al Obaaid, M.A., Al Sedairy, S.A., Al-Assaf, A.H., Zhang, J.J., Lei, K.Y., Tomato powder is more protective than lycopene supplement against lipid peroxidation in rats. Nutr Res 30 (2010), 66–73.
11. [11] Basu, A., Imrhan, V., Tomatoes versus lycopene in oxidative stress and carcinogenesis: conclusions from clinical trials. Eur J Clin Nutr 61 (2007), 295–303.
12. [12] Benakmoum, A., Abbeddou, S., Ammouche, A., Kefalas, P., Gerasopoulos, D., Valorisation of low quality edible oil with tomato peel waste. Food Chem 110 (2008), 684–690.
13. [13] Zou, Y., Li, J., Lu, C., Wang, J., Ge, J., Huang, Y., et al. High-fat emulsion-induced rat model of nonalcoholic steatohepatitis. Life Sci 79 (2006), 1100–1107.
14. [14] Wang, Y., Ausman, L.M., Greenberg, A.S., Russell, R.M., Wang, X.D., Dietary lycopene and tomato extract supplementations inhibit nonalcoholic steatohepatitis-promoted hepatocarcinogenesis in rats. Int J Cancer 126 (2010), 1788–1796.
15. [15] Gitenay, D., Lyan, B., Rambeau, M., Mazur, A., Rock, E., Comparison of lycopene and tomato effects on biomarkers of oxidative stress in vitamin E deficient rats. Eur J Nutr 46 (2007), 468–475.
16. [16] Fraulob, J.C., Ogg-Diamantino, R., Fernandes-Santos, C., Aguila, M.B., Mandarim-de-Lacerda, C.A., A mouse model of metabolic syndrome: insulin resistance, fatty liver and non-alcoholic fatty pancreas disease (NAFPD) in C57BL/6 mice fed a high fat diet. J Clin Biochem Nutr 46 (2010), 212–223.
17. [17] Froescheis, O., Moalli, S., Liechti, H., Bausch, J., Determination of lycopene in tissues and plasma of rats by normal-phase high-performance liquid chromatography with photometric detection. J Chromatogr B Biomed Sci Appl 739 (2000), 291–299.
18. [18] Postic, C., Girard, J., The role of the lipogenic pathway in the development of hepatic steatosis. Diabetes Metab 34 (2008), 643–648.
19. [19] Kusunoki, J., Kanatani, A., Moller, D.E., Modulation of fatty acid metabolism as a potential approach to the treatment of obesity and the metabolic syndrome. Endocrine 29 (2006), 91–100.
20. [20] Wakil, S.J., Abu-Elheiga, L.A., Fatty acid metabolism: target for metabolic syndrome. J Lipid Res 50 (2009), S138–S143 [Suppl.].
21. [21] Bernal, C., Martin-Pozuelo, G., Lozano, A.B., Sevilla, A., Garcia-Alonso, J., Canovas, M., et al. Lipid biomarkers and metabolic effects of lycopene from tomato juice on liver of rats with induced hepatic steatosis. J Nutr Biochem 24 (2013), 1870–1881.
22. [22] Lee, J.H., Cho, H.D., Jeong, J.H., Lee, M.K., Jeong, Y.K., Shim, K.H., et al. New vinegar produced by tomato suppresses adipocyte differentiation and fat accumulation in 3T3-L1 cells and obese rat model. Food Chem 141 (2013), 3241–3249.
23. [23] Tsitsimpikou, C., Tsarouhas, K., Kioukia-Fougia, N., Skondra, C., Fragkiadaki, P., Papalexis, P., et al. Dietary supplementation with tomato-juice in patients with metabolic syndrome: a suggestion to alleviate detrimental clinical factors. Food Chem Toxicol 74 (2014), 9–13.
24. [24] Kim, A.Y., Jeong, Y.-J., Park, Y.B., Lee, M.-K., Jeon, S.-M., McGregor, R.A., et al. Dose dependent effects of lycopene enriched tomato-wine on liver and adipose tissue in high-fat diet fed rats. Food Chem 130 (2012), 42–48.
25. [25] Ahuja, K.D., Pittaway, J.K., Ball, M.J., Effects of olive oil and tomato lycopene combination on serum lycopene, lipid profile, and lipid oxidation. Nutrition 22 (2006), 259–265.
26. [26] Hsu, Y.M., Lai, C.H., Chang, C.Y., Fan, C.T., Chen, C.T., Wu, C.H., Characterizing the lipid-lowering effects and antioxidant mechanisms of tomato paste. Biosci Biotechnol Biochem 72 (2008), 677–685.
27. [27] Luvizotto, R.A., Nascimento, A.F., Imaizumi, E., Pierine, D.T., Conde, S.J., Correa, C.R., et al. Lycopene supplementation modulates plasma concentrations and epididymal adipose tissue mRNA of leptin, resistin and IL-6 in diet-induced obese rats. Br J Nutr 110 (2013), 1803–1809.
28. [28] Gouranton, E., Aydemir, G., Reynaud, E., Marcotorchino, J., Malezet, C., Caris-Veyrat, C., et al. Apo-10'-lycopenoic acid impacts adipose tissue biology via the retinoic acid receptors. Biochim Biophys Acta Mol Cell Biol Lipids 1811 (2011), 1105–1114.
29. [29] Paolisso, G., Giugliano, D., Oxidative stress and insulin action: is there a relationship?. Diabetologia 39 (1996), 357–363.
30. [30] Shixian, Q., Dai, Y., Kakuda, Y., Shi, J., Mittal, G., Yeung, D., et al. Synergistic anti-oxidative effects of lycopene with other bioactive compounds. Food Rev Int 21 (2005), 295–311.
31. [31] Kong, K.W., Khoo, H.E., Prasad, K.N., Ismail, A., Tan, C.P., Rajab, N.F., Revealing the power of the natural red pigment lycopene. Molecules 15 (2010), 959–987.
32. [32] Zanfini, A., Corbini, G., La Rosa, C., Dreassi, E., Antioxidant activity of tomato lipophilic extracts and interactions between carotenoids and α-tocopherol in synthetic mixtures. LWT-Food Sci Technol 43 (2010), 67–72.
33. [33] Luvizotto, R.A., Nascimento, A.F., Miranda, N.C., Wang, X.D., Ferreira, A.L., Lycopene-rich tomato oleoresin modulates plasma adiponectin concentration and mRNA levels of adiponectin, SIRT1, and FoxO1 in adipose tissue of obese rats. Hum Exp Toxicol 34 (2015), 612–619.
34. [34] Turer, A.T., Scherer, P.E., Adiponectin: mechanistic insights and clinical implications. Diabetologia 55 (2012), 2319–2326.
35. [35] Comité d'experts des Lignes directrices de pratique clinique de l'Association canadienne du diabète, Lignes directrices de pratique clinique: Thérapie nutritionnelle. Can J Diabetes, 37, 2013, S409–S421.
36. [36] Frayn, K.N., Williams, C.M., Arner, P., Are increased plasma non-esterified fatty acid concentrations a risk marker for coronary heart disease and other chronic diseases?. Clin Sci (Lond) 90 (1996), 243–253.
37. [37] Il'yasova, D., Wang, F., D'Agostino, R.B. Jr., Hanley, A., Wagenknecht, L.E., Prospective association between fasting NEFA and type 2 diabetes: impact of post-load glucose. Diabetologia 53 (2010), 866–874.
38. [38] Byrne, C.D., Maison, P., Halsall, D., Martensz, N., Hales, C.N., Wareham, N.J., Cross-sectional but not longitudinal associations between non-esterified fatty acid levels and glucose intolerance and other features of the metabolic syndrome. Diabet Med 16 (1999), 1007–1015.
39. [39] Karpe, F., Dickmann, J.R., Frayn, K.N., Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes 60 (2011), 2441–2449.
40. [40] Aly, E., H, F., The effect of tomato pomace and paste on some biochemical aspects in serum and liver and antioxidant status of hypercholesterolemic rats. 2004.
41. [41] Ibrahim, H.S., Ahmed, L.A., El-din, M.M., The functional role of some tomato products on lipid profile and liver function in adult rats. J Med Food 11 (2008), 551–559.
42. [42] Story, E.N., Kopec, R.E., Schwartz, S.J., Harris, G.K., An update on the health effects of tomato lycopene. Annu Rev Food Sci Technol 1 (2010), 189–210.
43. [43] Manninen, V., Tenkanen, L., Koskinen, P., Huttunen, J.K., Manttari, M., Heinonen, O.P., et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki heart study. Implications for treatment. Circulation 85 (1992), 37–45.
44. [44] Griffin, B.A., Freeman, D.J., Tait, G.W., Thomson, J., Caslake, M.J., Packard, C.J., et al. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 106 (1994), 241–253.
45. [45] Berliner, J.A., Navab, M., Fogelman, A.M., Frank, J.S., Demer, L.L., Edwards, P.A., et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 91 (1995), 2488–2496.
46. [46] Pickup, J.C., Mattock, M.B., Chusney, G.D., Burt, D., NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40 (1997), 1286–1292.
47. [47] Luisa, B.M., Canas, J.A., Ribot, J., Palou, A., Carotenoids and their conversion products in the control of adipocyte function, adiposity and obesity. Arch Biochem Biophys 572 (2015), 112–125.
48. [48] Fuhrman, B., Elis, A., Aviram, M., Hypocholesterolemic effect of lycopene and beta-carotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophages. Biochem Biophys Res Commun 233 (1997), 658–662.
49. [49] Upritchard, J.E., Sutherland, W.H., Mann, J.I., Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care 23 (2000), 733–738.
50. [50] Andre, P., Balkau, B., Born, C., Royer, B., Wilpart, E., Charles, M.A., et al. Hepatic markers and development of type 2 diabetes in middle aged men and women: a three-year follow-up study. The D.E.S.I.R. Study (Data from an Epidemiological Study on the Insulin Resistance Syndrome). Diabetes Metab 31 (2005), 542–550.
51. [51] Schindhelm, R.K., Diamant, M., Dekker, J.M., Tushuizen, M.E., Teerlink, T., Heine, R.J., Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev 22 (2006), 437–443.
52. [52] Nannipieri, M., Gonzales, C., Baldi, S., Posadas, R., Williams, K., Haffner, S.M., et al. Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study. Diabetes Care 28 (2005), 1757–1762.
53. [53] Paschos, P., Paletas, K., Nonalcoholic fatty liver disease and metabolic syndrome. Hippokratia 13 (2009), 9–19.
54. [54] Day, C.P., James, O.F., Steatohepatitis: a tale of two "hits"?. Gastroenterology 114 (1998), 842–845.